Spinal Muscular Atrophy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 3 years old or older
- You have been diagnosed with Spinal Muscular Atrophy (SMA) and are a candidate for a drug called Spinraza (nusinersen)
- You have difficulty receiving spinal injections (lumbar punctures) safely — either because breathing problems or other health conditions make repeated anesthesia and X-ray exposure risky, or because your doctor believes the device being studied is otherwise in your best interest
- Your doctor has prescribed Spinraza to be delivered through a special implanted port system, and the first use of that port is planned within 2 weeks of the device being put in
- Your doctor determines you are able to have a surgical procedure (either minimally invasive or open surgery) to implant the port and catheter, with at least a small length of tubing placed in the spinal fluid space
- You (or your legal guardian) are willing and able to give written consent to participate
- You and your parent or caregiver are able and willing to attend all required study visits and complete all study procedures
Who may not be able to join:
- You have any health conditions that make the ThecaFlex DRx™ device unsafe for you to use (confirm with trial site)
- You have had, or currently have (within the last 6 months), another implanted drug delivery device, spinal catheter, fluid drainage shunt, or reservoir in the spinal fluid space
- You are pregnant, breastfeeding, or planning to become pregnant during the study
- You have severe physical characteristics that would make it unsafe to implant the catheter or port
- You have had a major medical event within the last 60 days
- You have had surgery involving the head, neck, or back within the last 60 days, or have such surgery planned during the study period
- You have certain structural brain or spine conditions, such as a mass pressing on brain or spinal tissue, a growth at the base of the skull, or a condition called Arnold-Chiari malformation (confirm with trial site)
- You have problems with blood clotting or low platelet levels
- You do not have enough skin or body tissue to safely cover and protect the implanted port
- You have a medical reason why you cannot receive Spinraza
- You have a history of a type of tissue growth (granuloma) forming around spinal catheters
- You have had a spinal fluid infection (bacterial or aseptic meningitis) within the last 6 months
- You have a history of tumors or other spinal abnormalities that would interfere with the catheter placement or spinal fluid flow
- You have a history of a condition causing fluid build-up in the brain (hydrocephalus)
- You have been diagnosed with another muscle-wasting disease in addition to SMA
- You have a history of depression, significant memory or thinking problems, or behavioural issues that your doctor believes could make participation unsafe
- Your doctor believes your current medical condition may mean a life expectancy of less than 12 months
- You are currently taking part in another medical device research study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 857-500-7526
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The proportion of subjects with successful Implantation of the ThecaFlex DRx™ Port and Catheter; The proportion of subjects with successful Intrathecal Therapy Infusion(s) through 12 months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.